Abstract:Abstract Background: Gene expression is determined by structural interactions in between transcription factors, cofactors and enhancer elements, as well as enhancer-promoter interactions (1). Both YY1 and CTCF are essential, zinc finger proteins that bind hypo-methylated DNA sequences, form homodimers, and thus facilitate DNA loop formation (1). However, YY1 preferentially occupies interacting enhancers and promoters, whereas CTCF preferentially occupies sites distal from these regulatory elements, forming larger loops and participating in insulation (1). A sequencing study of spontaneous functional insulinomas in a Chinese cohort identified a somatic a hotspot mutation in YY1 (c.C1115G/p.T372R) in 30% of the cases, associated with increased YY1 activity (2). YY1 is a critical transcription factor involved in the regulation of proliferation and metabolism (2). Hypothesis: YY1 loss-of-function alters energy source preference in pancreatic β-cells. Methods: YY1 stable loss-of-function in mouse insulinoma cell lines was achieved by shRNA lentiviral transduction. Mitochondrial membrane potential (MMP) was measured via flow cytometry of aggregated mitochondria to monomeric mitochondria ratio. Mitostress and complex-substrate controlled respiration were measured by Seahorse analyzer. Mitochondrial copy number was assessed by mitochondrial to nuclear DNA ratio. Quantitative qPCR and Western blotting were used to assess mitochondrial gene and protein expression. Results: Our data indicated that YY1 deficient β-cells showed increased MMP and maximal respiration. No significant differences were found in basal respiration, ATP production, proton leak, non-mitochondrial oxygen consumption or coupling efficiency. We also found that YY1 deficient β-cells exhibited reduced glycolytic capacity and decreased ETC complex IV activity, with concurrent increased complex I and II activity. In addition, YY1 deficient β-cells exhibited elevated mitochondrial copy number and increased quantitative mRNA of mitochondrial gene expression, which could be correlated with increased PGC1-α expression. Conclusions: YY1 is critical in the metabolic regulation of β-cells, particularly in the facilitation of glycolytic metabolism. YY1 activating mutations in functional spontaneous insulinoma cells can lead to a proliferation dysregulation accompanied by a metabolic switch that favors glycolysis, while the opposite occurs in YY1 deficient β-cells. References: (1) Weintraub AS et al, Cell 2017 Dec 14; 171:1573–1588 (2) Cao Y et al, Nat Commun 2013 Dec 10; 4:2810

YY1 Deficiency in Β-Cells Leads to Mitochondrial Dysfunction and Diabetes in Mice.

Yy1 Depletion in Pancreatic Beta Cells Leads to Energy Source Switch from Glycolysis to Oxidative Phosphorylation

YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis

YY1 inactivated transcription co-regulator PGC-1a to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis ( Apr, 10.1007/s10565-022-09711-7, 2022)

Correction to: YY1 inactivated transcription co‐regulator PGC‐1α to promote mitochondrial dysfunction of early diabetic nephropathy‐associated tubulointerstitial fibrosis

Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review

Downregulation of the m6A reader protein YTHDC1 leads to islet β-cell failure and diabetes

Deficiency of Voltage-gated Proton Channel Hv1 Leads to hypoinsulinaemia, hyperglycemia and glucose intolerance in mice

Nuclear Factor-Y in Mouse Pancreatic Β-Cells Plays a Crucial Role in Glucose Homeostasis by Regulating Β-Cell Mass and Insulin Secretion

YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration

Yin Yang 1 promotes hepatic gluconeogenesis through upregulation of glucocorticoid receptor

YY1: A Novel Therapeutic Target for Diabetic Nephropathy Orchestrated Renal Fibrosis.

Contribution of Increased Expression of Yin Yang 2 to Development of Cardiomyopathy.

Brown Adipose YY1 Deficiency Activates Expression of Secreted Proteins Linked to Energy Expenditure and Prevents Diet-Induced Obesity

YY1 is Required for Posttranscriptional Stability of SOX2 and OCT4 Proteins.

Multifunctional YY1 in Liver Diseases

Nuclear factor-Y mediates pancreatic -cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress

Nuclear factor-Y mediates pancreatic β-cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress

Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation

Supplementary Figures S1-S8 from Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway

Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function